GlassScriptPhysician profile
Noopur Ghade
NPI 1073977617
$3,602.89
in general payments reported to CMS, 2019-2025
19 companies · $50.86 in 2025
The $50.86 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $105 · 2021: $608 · 2022: $572 · 2024: $2,266 · 2025: $50.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $542 · Travel and Lodging: $266 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $542.43 |
| Travel and Lodging | $266.10 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,244.24 | 2024 | |
| Abbvie INC. | $384.13 | 2020-2022 | |
| Gynesonics, INC. | $212.37 | 2022 | |
| Amgen INC. | $150.78 | 2022 | |
| Myovant Sciences INC. | $95.06 | 2021-2022 | |
| Daiichi Sankyo INC. | $78.59 | 2021 | |
| Sage Therapeutics, LLC | $66.61 | 2021-2022 | |
| Hologic Sales and Service, LLC | $62.94 | 2021-2025 | Aptima, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $48.43 | 2021 | |
| Becton, Dickinson and Company | $42.07 | 2021 | |
| Merck Sharp & Dohme LLC | $38.97 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $38.09 | 2021-2022 | |
| Scynexis, INC. | $30.31 | 2022 | |
| Coopersurgical, INC. | $26.81 | 2025 | Paragard T 380a |
| Evofem Biosciences, INC. | $20.46 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20.03 | 2021 | |
| Roche Diagnostics Corporation | $15.96 | 2021 | |
| Medicem INC. | $13.90 | 2021 | |
| Lupin INC. | $13.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noopur Ghade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.